Skip to main content
. 2021 Jul 6;9(19):5046–5053. doi: 10.12998/wjcc.v9.i19.5046

Table 1.

Clinical and pathological features of patients with primary breast cancer

Clinical or pathological feature
n (%)
< 40 yr 34 (22.8)
40-59 yr 92 (61.8)
≥ 60 yr 23 (15.4)
Stage 0 16 (10.7)
Stage I 46 (30.9)
Stage II 57 (38.3)
Stage III 27 (18.1)
Stage IV 3 (2.0)
Luminal A 31 (20.8)
Luminal B (HER2 negative) 54 (36.2)
Luminal B (HER2 positive) 39 (26.2)
HER2 over expression type 11 (7.4)
Three negative type 14 (9.4)

HER2: Human epidermal growth factor receptor 2.